Difference between revisions of "Osta WA, et al. Cancer Res. (2004) cited as Ref 559 in DOI: 10.1038/s41392-020-0110-5 (Q9822)"
Jump to navigation
Jump to search
(Created claim: title (P93): EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy, #quickstatements; #temporary_batch_1590010982689) |
(Created claim: Page(s) (P105): 5818-5824, #quickstatements; #temporary_batch_1590074839150) |
||
| Property / Page(s) | |||
| + | 5818-5824 | ||
| Property / Page(s): 5818-5824 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:45, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Osta WA, et al. Cancer Res. (2004) cited as Ref 559 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Osta WA
0 references
2004
0 references
Cancer Res.
0 references
64
0 references
EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy (English)
0 references
5818-5824
0 references
